Physician profile
Charles H Smith
NPI 1659337608
$22,275.94
in general payments reported to CMS, 2019-2025
16 companies · $771 in 2025
The $771 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $836 · 2020: $3,169 · 2021: $674 · 2022: $993 · 2023: $8,044 · 2024: $7,790 · 2025: $771.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,600 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,050 · Food and Beverage: $2,768 · Travel and Lodging: $1,187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,600.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,050.00 |
| Food and Beverage | $2,767.96 |
| Travel and Lodging | $1,186.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $15,531.28 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Edwards Lifesciences Corporation | $4,005.94 | 2019-2025 | Sapien 3 Ultra Resilia |
| Abiomed | $1,616.42 | 2022-2025 | Impella |
| Boston Scientific Corporation | $239.15 | 2022-2025 | Enroute Transcarotid Neuroprotection System, Lux-Dx Insertable Cardiac Monitor |
| W. L. Gore & Associates, INC. | $185.58 | 2019-2024 | Viabahn Endoprosthesis With Propaten Bioactive Surface |
| Atricure, INC. | $143.71 | 2025 | Synergy Ablation System |
| Abbott Laboratories | $126.24 | 2019-2022 | |
| Medtronic, INC. | $91.08 | 2021-2025 | Endurant Iis, Corevalve Evolut R |
| On Target Laboratories, INC | $87.89 | 2024 | Cytalux |
| Medtronic Vascular, INC. | $80.56 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $70.00 | 2022 | |
| Bard Peripheral Vascular, INC. | $24.37 | 2020 | |
| Lemaitre Vascular, INC. | $24.04 | 2025 | Xenosure Biologic Patch |
| Medinc of Texas | $19.64 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $15.82 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surmodics, INC. | $14.22 | 2025 | Pounce Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight, Pounce Venous Thrombectomy System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.